Among patients with CHD, Geenen et al. [7] found in a prospective cohort study of 602 adult patients with CHD that hs-CRP carried out an incremental prognostic value for the risk of death or heart failure, beyond the NT-pro-BNP concentration. This evidence concerns the gene NPPB and coronary artery disorder.